Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants
The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses.